ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 267

$471K Total Retail Price of All Prescriptions

Rank: 29 out of 267

417 Patients Receiving at Least One Drug in Part D
93% Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in North Dakota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

21% of this provider’s 417 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 417 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
FUROSEMIDE 596 566 89 1 4
OMEPRAZOLE 513 474 77 2 5
LEVOTHYROXINE SODIUM 437 397 50 3 2
SERTRALINE HCL 418 386 59 4 14
FENTANYL 350 327 53 S2 5 42
HYDROCHLOROTHIAZIDE 302 302 33 6 7
POTASSIUM CHLORIDE 301 285 49 7 10
HYDROCODONE-ACETAMINOPHEN 250 219 61 S3 8 15
MIRTAZAPINE 240 229 47 9 35
LISINOPRIL 235 220 38 10 3
LORAZEPAM 218 181 54 B 11 26
METOPROLOL TARTRATE 215 210* 36 12 8
CITALOPRAM HBR 211 170 34 13 23
AMLODIPINE BESYLATE 195 190* 24 14 6
POLYETHYLENE GLYCOL 3350 189 176 39 15 41
GABAPENTIN 180 163 27 16 17
WARFARIN SODIUM 178 173* 18 17 13
METOPROLOL SUCCINATE 153 148* 27 18 11
ATENOLOL 143 143 21 19 18
JANTOVEN 140 126 23 20 40
RISPERIDONE 134 120 25 A 21 59
CLOPIDOGREL 118 118 19 22 20
DIGOX 117 105 14 23 45
CYMBALTA 117 117 15 23 54
ROPINIROLE HCL 113 101 12 25 78
ALLOPURINOL 112 100 12 26 22
LANTUS 110 96 18 27 56
NAMENDA 108 108 12 28 31
ISOSORBIDE MONONITRATE ER 107 107 14 29 34
FLUOXETINE HCL 104 93 15 30 52
TAMSULOSIN HCL 104 86 17 30 24
CLONAZEPAM 102 84 14 B 32 65
TRAMADOL HCL 99 86 25 33 19
CARBIDOPA-LEVODOPA 87 87 11 34 84
DONEPEZIL HCL 87 87 11 34 21
TRIAMCINOLONE ACETONIDE 81 76* 35 36 116
FINASTERIDE 79 <11 <11 37 71
DIOVAN 77 <11 <11 38 58
ENALAPRIL MALEATE 77 58 13 38 32
CIPROFLOXACIN HCL 72 67* 50 40 57
QUETIAPINE FUMARATE 72 <11 <11 A 40 51
TRAZODONE HCL 70 42 18 42 36
IPRATROPIUM-ALBUTEROL 70 65* 14 42 93
CARVEDILOL 69 64* 14 44 30
LEVETIRACETAM 68 <11 <11 45 102
NEXIUM 68 <11 <11 45 61
LOSARTAN POTASSIUM 68 68 12 45 16
ATORVASTATIN CALCIUM 67 67 12 48 9
FLUTICASONE PROPIONATE 67 62* 22 48 50
METFORMIN HCL 65 65 11 50 12
LANTUS SOLOSTAR 64 <11 <11 51 44
DETROL LA 63 <11 <11 52 86
SIMVASTATIN 59 59 16 53 1
DIVALPROEX SODIUM 57 36 13 54 106
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 <11 <11 54 25
PROMETHAZINE HCL 56 36 16 R 56 159
LATANOPROST 56 <11 <11 56 127
ALPRAZOLAM 55 50* 12 B 58 47
PREDNISONE 54 49* 18 59 29
OLANZAPINE 53 <11 <11 A 60 114
BUDESONIDE 51 <11 <11 61 181
VENLAFAXINE HCL ER 50 <11 <11 62 68
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.